Antidepressant of J&J leads to FDA; SCLC m...

The Mini brains grown in a dish have produced human-like brain waves. They are the electrical patterns look similar to those of premature babies. This would aid scientists to study early brain development. The research in this area has been sluggish, partly because it is difficult to obtain fetal-tissue samples for ...

A new technique that makes dead mice transparent and hard like plastic is giving a cue to researchers an unprecedented view of how different types of cell interact in the body. The technique, called vDISCO, has already disclosed astonishing structural connections between organs, including cues about the extent to wh...

Millions of people get bad side-effects when trying to withdraw antidepressants. The All Party Parliamentary Group for Prescribed Drug Dependence review shows half of the patients have withdrawal symptoms and for half of these, the symptoms will be severe. The patients should be properly warned for the same.The revi...

Food and Drug Administration repudiates ADHD drug by Sunovion Sunovion’s ADHD drug for the treatment of attention-deficit hyperactivity disorder (ADHD) has not been accepted by the Food and Drug Administration, FDA. It is so because the drug for ADHD treatment in its current form needs additional clinical trials and...

Diverse voltage and ligand gated ion channels mediate Neuron excitation through various ions by sending electrical signals. Calcium is critical for cellular functioning. Voltage-gated calcium channels are primary mediators of depolarization-induced calcium entry into neurons. Calcium ions act as membrane potentiatio...

Biohaven Completes Enrollment of Rimegepant in Second Pivotal Phase 3 Clinical Trial for the treatment of Migraine Biohaven Pharmaceutical has recently announced the completion of enrollment of their study BHV3000-302 in Phase 3. The company is examining the safety and efficacy of Rimegepant for the treatment of Mi...